Stratagen Bio
Gregory Ekchian is a distinguished entrepreneur and scientist with a robust background in materials science and engineering. As Co-Founder and CEO of Stratagen Bio since September 2021, Gregory has leveraged extensive experience from previous roles, including Blavatnik Fellow in Life Science Entrepreneurship at Harvard Business School and Postdoctoral Fellow at the Massachusetts Institute of Technology. Academic credentials include a Ph.D. and a Master of Engineering in Materials Science and Engineering from MIT, along with a Bachelor of Science in Biomedical Engineering from Boston University. Notable contributions also include leadership positions at the Martin Trust Center for MIT Entrepreneurship and practical engineering roles at SpringLeaf Therapeutics and Kinematix Corporation.
This person is not in any teams
Stratagen Bio
Stratagen Bio’s oxygen sensing technology was developed in labs at MIT’s Koch Institute for Integrative Cancer Research and the Department of Materials Science and Engineering. We are committed to developing high impact technologies to enable clinicians to make more informed treatment decisions and improve patient care.